imatinib mesylate has been researched along with Pleural Effusion, Malignant in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amadori, D; Bongiovanni, A; Calpona, S; Cavaliere, D; De Vita, A; Foca, F; Gunelli, E; Ibrahim, T; La Manna, F; Liverani, C; Mercatali, L; Oboldi, D; Pieri, F; Ricci, M; Riva, N | 1 |
| Agalioti, T; Aidinis, V; Apostolopoulou, H; Blackwell, TS; Eickelberg, O; Feyerabend, TB; Giannou, AD; Giopanou, I; Harokopos, V; Iwakura, Y; Kairi, CA; Kalomenidis, I; Kanellakis, NI; Kardamakis, D; Lilis, I; Marazioti, A; Papadaki, H; Papaleonidopoulos, V; Patmanidi, AL; Prijovich, ZM; Psallidas, I; Rodewald, HR; Snyder, LA; Spella, M; Spiropoulou, N; Spyratos, D; Stathopoulos, GT; Taraviras, S; Teliousi, S; Vreka, M; Zazara, DE | 1 |
| Cornelissen, JJ; Schnog, JB; Van Hest, RM; Van't Veer, MB | 1 |
| Davion, S; Kulesza, P; Nayar, R; Rohan, S | 1 |
| Hong, RL; Hsu, C; Jeng, YM; Lin, CH; Tzen, CY; Yen, RF | 1 |
1 review(s) available for imatinib mesylate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Metastatic chromophobe renal cell carcinoma in pleural fluid cytology: review of literature and report of a case.
Topics: Benzamides; Carcinoma, Renal Cell; Cell Membrane; Cytoplasm; Humans; Imatinib Mesylate; Immunohistochemistry; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Pleura; Pleural Effusion, Malignant; Proto-Oncogene Proteins c-kit; Pyrimidines | 2012 |
1 trial(s) available for imatinib mesylate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Benzamides; Carcinoma, Adenoid Cystic; Disease Progression; DNA Mutational Analysis; Female; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Piperazines; Pleural Effusion, Malignant; Protein-Tyrosine Kinases; Pyrimidines | 2005 |
3 other study(ies) available for imatinib mesylate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report.
Topics: Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Pleural Effusion, Malignant; Pyrimidines; Radiography; Treatment Outcome | 2014 |
Mast cells mediate malignant pleural effusion formation.
Topics: Adenocarcinoma; Animals; Benzamides; Cell Line, Tumor; Colonic Neoplasms; Humans; Imatinib Mesylate; Interleukin-1beta; Lung Neoplasms; Male; Mast Cells; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Piperazines; Pleural Cavity; Pleural Effusion, Malignant; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Tryptases | 2015 |
Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Drug Interactions; Edema; Etoposide; Female; Humans; Imatinib Mesylate; Leucovorin; Methotrexate; Middle Aged; Piperazines; Pleural Effusion, Malignant; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sodium Potassium Chloride Symporter Inhibitors; Translocation, Genetic | 2008 |